Screener
ImmunityBio, Inc. IBRX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 26,182 | 27,761 |
| Prepaid expenses – related parties | 2,071 | 769 |
| Total current assets | 452,953 | 314,875 |
| Property, plant and equipment, net | 112,785 | 114,264 |
| Goodwill and intangible assets, net | 12,885 | 13,953 |
| Long-term inventories | 18,856 | 13,508 |
| Convertible note receivable | — | 7,380 |
| Operating lease right-of-use assets, net | 20,573 | 19,808 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s PP&E (net)?
- ImmunityBio, Inc. (IBRX) reported PP&E (net) of $112.79M in Q1 2026.
- How has ImmunityBio, Inc.'s PP&E (net) changed year-over-year?
- ImmunityBio, Inc.'s PP&E (net) decreased by 16.6% year-over-year, from $135.27M to $112.79M.
- What is the long-term trend for ImmunityBio, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s PP&E (net) has grown at a 9.5% compound annual growth rate (CAGR), from $72.54M to $114.26M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about ImmunityBio, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude